{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:51:36Z","timestamp":1790200296926,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1208\/s12249-018-0986-3","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T17:28:13Z","timestamp":1520875693000},"page":"1699-1711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement"],"prefix":"10.1208","volume":"19","author":[{"given":"Sanyog","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Kumar","family":"Swarnakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kushwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer S.","family":"Katiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"issue":"2","key":"986_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/AAC.34.2.183","volume":"34","author":"J Brajtburg","year":"1990","unstructured":"Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother. 1990;34(2):183\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"986_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","volume":"12","author":"HA Gallis","year":"1990","unstructured":"Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12(2):308\u201329.","journal-title":"Rev Infect Dis"},{"issue":"4","key":"986_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","unstructured":"Laniado-Labor\u00edn R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam Micol. 2009;26(4):223\u20137.","journal-title":"Rev Iberoam Micol"},{"issue":"6","key":"986_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","volume":"26","author":"J Italia","year":"2009","unstructured":"Italia J, Yahya M, Singh D, Kumar MR. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone\u00ae. Pharm Res. 2009;26(6):1324\u201331.","journal-title":"Pharm Res"},{"key":"986_CR5","doi-asserted-by":"crossref","unstructured":"Prajapati VK, Awasthi K, Yadav TP, Rai M, Srivastava ON, Sundar S. An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis. J Infect Dis. 2011; jir735.","DOI":"10.1093\/infdis\/jir735"},{"issue":"8","key":"986_CR6","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1128\/AAC.46.8.2704-2707.2002","volume":"46","author":"G Delmas","year":"2002","unstructured":"Delmas G, Park S, Chen Z, Tan F, Kashiwazaki R, Zarif L, et al. Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrob Agents Chemother. 2002;46(8):2704\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"986_CR7","doi-asserted-by":"crossref","unstructured":"Gershkovich P, Wasan EK, Lin M, Sivak O, Leon CG, Clement JG, et al. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. J Antimicrob Chemother. 2009; dkp140.","DOI":"10.1093\/jac\/dkp140"},{"issue":"12","key":"986_CR8","doi-asserted-by":"publisher","first-page":"e913","DOI":"10.1371\/journal.pntd.0000913","volume":"4","author":"EK Wasan","year":"2010","unstructured":"Wasan EK, Gershkovich P, Zhao J, Zhu X, Werbovetz K, Tidwell RR, et al. A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model. PLoS Negl Trop Dis. 2010;4(12):e913.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"986_CR9","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1021\/mp300320d","volume":"9","author":"S Jain","year":"2012","unstructured":"Jain S, Valvi PU, Swarnakar NK, Thanki K. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol Pharm. 2012;9(9):2542\u201353.","journal-title":"Mol Pharm"},{"issue":"4","key":"986_CR10","first-page":"354","volume":"6","author":"MB Chaudhari","year":"2016","unstructured":"Chaudhari MB, Desai PP, Patel PA, Patravale VB. Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module. Drug Deliv Transl Res. 2016;6(4):354\u201364.","journal-title":"Drug Deliv Transl Res"},{"key":"986_CR11","doi-asserted-by":"crossref","unstructured":"Takemoto K, Kanazawa K. AmBisome: relationship between the pharmacokinetic characteristics acquired by liposomal formulation and safety\/efficacy. J Liposome Res. 2016; 1\u20139.","DOI":"10.1080\/08982104.2016.1205087"},{"issue":"6","key":"986_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jps.1023","volume":"90","author":"T Lian","year":"2001","unstructured":"Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90(6):667\u201380.","journal-title":"J Pharm Sci"},{"issue":"3","key":"986_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/mmy\/myv111","volume":"54","author":"JP Adler-Moore","year":"2016","unstructured":"Adler-Moore JP, Gangneux J-P, Pappas PG. Comparison between liposomal formulations of amphotericin B. Sabouraudia. 2016;54(3):223\u201331.","journal-title":"Sabouraudia"},{"key":"986_CR14","first-page":"3703","volume":"7","author":"N Zeng","year":"2012","unstructured":"Zeng N, Gao X, Hu Q, Song Q, Xia H, Liu Z, et al. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption. Int J Nanomedicine. 2012;7:3703\u201318.","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"986_CR15","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1021\/nl050678i","volume":"5","author":"J Barauskas","year":"2005","unstructured":"Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstructures: beyond vesicles and liposomes. Nano Lett. 2005;5(8):1615\u20139.","journal-title":"Nano Lett"},{"issue":"9\u201310","key":"986_CR16","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1166\/jnn.2006.402","volume":"6","author":"M Johnsson","year":"2006","unstructured":"Johnsson M, Barauskas J, Norlin A, Tiberg F. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. J Nanosci Nanotechnol. 2006;6(9\u201310):3017\u201324.","journal-title":"J Nanosci Nanotechnol"},{"issue":"5","key":"986_CR17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1021\/mp400601g","volume":"11","author":"NK Swarnakar","year":"2014","unstructured":"Swarnakar NK, Thanki K, Jain S. Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro\u2013in vivo relationships. Mol Pharm. 2014;11(5):1435\u201349.","journal-title":"Mol Pharm"},{"issue":"5","key":"986_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s11095-013-1244-8","volume":"31","author":"NK Swarnakar","year":"2014","unstructured":"Swarnakar NK, Thanki K, Jain S. Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Pharm Res. 2014;31(5):1219\u201338.","journal-title":"Pharm Res"},{"issue":"28","key":"986_CR19","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1016\/j.biomaterials.2011.05.079","volume":"32","author":"NK Swarnakar","year":"2011","unstructured":"Swarnakar NK, Jain AK, Singh RP, Godugu C, Das M, Jain S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials. 2011;32(28):6860\u201374.","journal-title":"Biomaterials"},{"issue":"3","key":"986_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1208\/s12249-009-9292-4","volume":"10","author":"J Lai","year":"2009","unstructured":"Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z, et al. Glyceryl monooleate\/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS PharmSciTech. 2009;10(3):960\u20136.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"986_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","volume":"396","author":"L Gan","year":"2010","unstructured":"Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm. 2010;396(1):179\u201387.","journal-title":"Int J Pharm"},{"key":"986_CR22","first-page":"327","volume":"9","author":"Z Yang","year":"2014","unstructured":"Yang Z, Chen M, Yang M, Chen J, Fang W, Xu P. Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection. Int J Nanomedicine. 2014;9:327.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"986_CR23","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1007\/s11095-015-1706-2","volume":"32","author":"S Jain","year":"2015","unstructured":"Jain S, Bhankur N, Swarnakar NK, Thanki K. Phytantriol based \u201cstealth\u201d lyotropic liquid crystalline nanoparticles for improved antitumor efficacy and reduced toxicity of docetaxel. Pharm Res. 2015;32(10):3282\u201392.","journal-title":"Pharm Res"},{"issue":"6","key":"986_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.nano.2014.03.003","volume":"10","author":"NK Swarnakar","year":"2014","unstructured":"Swarnakar NK, Thanki K, Jain S. Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using doxorubicin-and coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin. Nanomedicine. 2014;10(6):1231\u201341.","journal-title":"Nanomedicine"},{"issue":"23","key":"986_CR25","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1021\/la061706v","volume":"22","author":"Y-D Dong","year":"2006","unstructured":"Dong Y-D, Larson I, Hanley T, Boyd BJ. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir. 2006;22(23):9512\u20138.","journal-title":"Langmuir"},{"issue":"23","key":"986_CR26","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.drudis.2010.09.006","volume":"15","author":"C Guo","year":"2010","unstructured":"Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15(23):1032\u201340.","journal-title":"Drug Discov Today"},{"issue":"19","key":"986_CR27","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1021\/la010161w","volume":"17","author":"PT Spicer","year":"2001","unstructured":"Spicer PT, Hayden KL, Lynch ML, Ofori-Boateng A, Burns JL. Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir. 2001;17(19):5748\u201356.","journal-title":"Langmuir"},{"key":"986_CR28","unstructured":"Jain S, Chauhan D, Jain A, Swarnakar N, Harde H, Mahajan R, et al. Stabilization of the nanodrug delivery systems by lyophilization using universal step-wise freeze drying cycle. Indian Patent Application No 2559\/DEL. 2011 filed on September. 2011."},{"issue":"4","key":"986_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1211\/0022357022935","volume":"56","author":"M Vertzoni","year":"2004","unstructured":"Vertzoni M, Fotaki N, Nicolaides E, Reppas C, Kostewicz E, Stippler E, et al. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J Pharm Pharmacol. 2004;56(4):453\u201362.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"986_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijpharm.2015.03.065","volume":"486","author":"R Swami","year":"2015","unstructured":"Swami R, Singh I, Jeengar MK, Naidu V, Khan W, Sistla R. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting. Int J Pharm. 2015;486(1):287\u201396.","journal-title":"Int J Pharm"},{"issue":"2","key":"986_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbamem.2004.05.003","volume":"1664","author":"M Larabi","year":"2004","unstructured":"Larabi M, Gulik A, Dedieu J-P, Legrand P, Barratt G, Cheron M. New lipid formulation of amphotericin B: spectral and microscopic analysis. Biochim Biophys Acta Biomembr. 2004;1664(2):172\u201381.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"4","key":"986_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11095-013-1213-2","volume":"31","author":"AK Jain","year":"2014","unstructured":"Jain AK, Thanki K, Jain S. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharm Res. 2014;31(4):923\u201345.","journal-title":"Pharm Res"},{"key":"986_CR33","doi-asserted-by":"crossref","unstructured":"Chen Y, Ma P, Gui S. Cubic and hexagonal liquid crystals as drug delivery systems. BioMed Res Int. 2014;2014.","DOI":"10.1155\/2014\/815981"},{"issue":"4","key":"986_CR34","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1208\/s12249-012-9876-2","volume":"13","author":"Z Yang","year":"2012","unstructured":"Yang Z, Tan Y, Chen M, Dian L, Shan Z, Peng X, et al. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech. 2012;13(4):1483\u201391.","journal-title":"AAPS PharmSciTech"},{"key":"986_CR35","first-page":"4","volume":"2011","author":"Z Yang","year":"2011","unstructured":"Yang Z, Peng X, Tan Y, Chen M, Zhu X, Feng M, et al. Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes. J Nanomater. 2011;2011:4.","journal-title":"J Nanomater"},{"key":"986_CR36","doi-asserted-by":"crossref","unstructured":"Sabliov C, Chen H, Yada R. Nanotechnology and functional foods: effective delivery of bioactive ingredients. Wiley; 2015.","DOI":"10.1002\/9781118462157"},{"issue":"12","key":"986_CR37","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s11095-007-9409-y","volume":"24","author":"NK Swarnakar","year":"2007","unstructured":"Swarnakar NK, Jain V, Dubey V, Mishra D, Jain N. Enhanced oromucosal delivery of progesterone via hexosomes. Pharm Res. 2007;24(12):2223\u201330.","journal-title":"Pharm Res"},{"issue":"2","key":"986_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jconrel.2011.03.033","volume":"153","author":"T-H Nguyen","year":"2011","unstructured":"Nguyen T-H, Hanley T, Porter CJ, Boyd BJ. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Control Release. 2011;153(2):180\u20136.","journal-title":"J Control Release"},{"issue":"11","key":"986_CR39","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1002\/jps.21724","volume":"98","author":"S Rizwan","year":"2009","unstructured":"Rizwan S, Hanley T, Boyd B, Rades T, Hook S. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci. 2009;98(11):4191\u2013204.","journal-title":"J Pharm Sci"},{"issue":"5","key":"986_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.2042-7158.1988.tb05260.x","volume":"40","author":"D Forster","year":"1988","unstructured":"Forster D, Washington C, Davis S. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. J Pharm Pharmacol. 1988;40(5):325\u20138.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"986_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.biomaterials.2010.09.037","volume":"32","author":"AK Jain","year":"2011","unstructured":"Jain AK, Swarnakar NK, Godugu C, Singh RP, Jain S. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials. 2011;32(2):503\u201315.","journal-title":"Biomaterials"},{"key":"986_CR42","first-page":"1","volume":"1","author":"PA Patel","year":"2013","unstructured":"Patel PA, Fernandes CB, Pol AS, Patravale VB. Oral amphotericin B: challenges and avenues. Int J Pharm Biosci Technol. 2013;1:1\u20139.","journal-title":"Int J Pharm Biosci Technol"},{"issue":"1","key":"986_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbamem.2006.01.001","volume":"1758","author":"PL Hargreaves","year":"2006","unstructured":"Hargreaves PL, Nguyen T-S, Ryan RO. Spectroscopic studies of amphotericin B solubilized in nanoscale bilayer membranes. Biochim Biophys Acta Biomembr. 2006;1758(1):38\u201344.","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-0986-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-0986-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-0986-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T14:49:29Z","timestamp":1570891769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-0986-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-0986-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,12]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal study protocols were duly approved by Institutional Animal Ethics Committee (IAEC), NIPER, India.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}